Global Medical REIT Inc. Board Declares 2025 Second Quarter Common and Preferred Dividends

Global Medical REIT Inc. (NYSE: GMRE), a net-lease medical real estate investment trust specializing in the acquisition of healthcare facilities, has announced the declaration of its second quarter dividends for 2025. The Company's Board of Directors has approved a cash dividend of $0.15 per share for common stockholders and unitholders, payable on July 9, 2025. To be eligible for this dividend, investors must be recorded as shareholders by June 20, 2025. This announcement reflects GMRE's ongoing commitment to providing steady returns to its investors.

In addition to the common dividend, GMRE has declared a cash dividend of $0.46875 per share on its Series A Cumulative Redeemable Preferred Stock. This dividend is payable on July 31, 2025, to Series A Preferred stockholders of record as of July 15, 2025. The declared dividend covers the period from April 30, 2025, to July 30, 2025, underscoring GMRE's reliable dividend policy.

Global Medical REIT focuses on leasing healthcare facilities to various stakeholders, including physician groups and both regional and national healthcare systems. The Company aims to create value through the strategic acquisition of properties that meet the evolving needs of the healthcare sector. Interested investors can find additional information, including an updated investor presentation, on the Company’s website.

The announcement also includes cautionary statements about forward-looking statements, emphasizing that actual results may differ due to various risks and uncertainties. Investors are encouraged to review GMRE's risk factors detailed in their annual and quarterly reports filed with the SEC.

For media inquiries, Stephen Swett can be contacted via email or telephone for further information about the Company’s operations and dividend announcements.

Global Medical REIT Inc. (NYSE: GMRE) has made a notable commitment to its investors by declaring its 2025 second quarter common and preferred dividends. The Board's decision to declare a common cash dividend of $0.15 per share and a preferred cash dividend of $0.46875 per share reflects the company’s sustained focus on stability and shareholder returns amidst the evolving healthcare landscape.

As a net-lease medical REIT, GMRE benefits from the rising demand for healthcare services and facilities. The company's strategy of acquiring and leasing properties to healthcare providers ensures a steady cash flow, which is crucial for supporting consistent dividend payouts. The recent dividend declaration signals a strong operational performance and a commitment to shareholder value, which can be attractive indicators for potential investors.

When considering an investment in GMRE, it’s essential to assess both the immediate dividend yield and the company's long-term growth potential. The common dividend yield can be calculated based on the projected dividend payouts relative to the current stock price, which will provide insights into its attractiveness as a potential income-generating asset. Additionally, investors should evaluate the healthcare sector's overall growth projections, especially as telehealth and chronic care management continue to gain traction post-pandemic.

However, potential investors should remain cautious about the inherent risks associated with REITs, including interest rate fluctuations, regulatory changes, and the specific operational risks tied to healthcare real estate. GMRE’s reliance on the performance of healthcare tenants means that any decline in the sector could impact revenues and, by extension, dividend payouts.

In summary, while GMRE is taking promising steps towards rewarding its investors, potential shareholders should conduct thorough due diligence to align their investment strategy with their risk tolerance and income objectives.